Alina BAUM
8Patents
3h-index
14Co-inventors
43Inventor score
Filing activity: Jun 25, 2020 → Jun 29, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10787501B1 | Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments | Emerging Cross-Sectional Technologies | 32 | Active |
| US10954289B1 | Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments | Emerging Cross-Sectional Technologies | 12 | Active |
| US10975139B1 | Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragments | Emerging Cross-Sectional Technologies | 4 | Active |
| US11732030B2 | Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments | Emerging Cross-Sectional Technologies | 1 | Active |
| US11999799B2 | Anti-TMPRSS2 antibodies and antigen-binding fragments | Chemistry; Metallurgy | 0 | Active |
| US12251440B2 | Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments | Emerging Cross-Sectional Technologies | 0 | Active |
| US11773156B2 | Anti-hemagglutinin antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11752214B2 | Protein-antiviral compound conjugates | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.